Monday, October 26, 2026 · Daily editionET --:--:--

Finished

LONG TERM FOLLOW UP AFTER PEDIATRIC SINGLE SITE ROBOTIC CHOLECYSTECTOMY

NCT07383961 · Good Samaritan Hospital Medical Center, New York · Updated 3 Feb 2026

What is being tested
Not stated
For
Robotic Surgical Procedure
Kind of study
Watches patients without assigning a treatment. No drug phase (a device or procedure study).
Who can join
Ages 15 years and older. About 150 people. The full rules are on the registry page.
Where
United States
When
Starts or started 1 Aug 2025, ends 31 Dec 2025. Registered 3 Feb 2026.
Results
None posted yet.

In the researchers' words

Robotic single-site cholecystectomy (RSSC) was first reported in children the PI from GSH in 2015, demonstrating the feasibility, safety, and short learning curve associated with RSSC. The primary advantages of RSSC identified in pediatric patients include superior cosmetic outcomes, reduced postoperative pain, and a shorter learning curve for surgeons compared to SILC. These benefits contribute to its growing acceptance among pediatric surgeons. However, despite clear short-term benefits, the need for evaluating long-term outcomes in pediatric populations remains unmet. There are currently no studies reporting long-term complications or cosmetic satisfaction following RSSC in pediatric patients. This study will attempt to evaluate the long term outcomes after RSSC and compare them with the current gold standard, multiport laparoscopic cholecystectomy, performed by the same surgeon at the same institution over a similar time frame.
ClinicalTrials.gov, NCT07383961

Sites

  • Good Samaritan University HospitalWest Islip, New York, United States